Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
Article in Basic Research in Cardiology (July 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Basic Research in Cardiology (July 2024)
Article in American Journal of Physiology - Cell Physiology (June 2024)
Article in Biomedicine & Pharmacotherapy (April 2024)